| 761 Modulating the therapeutic response of tumours to dietary serine and glycine starvation.
760 The cross-talk between immune cells and blood vessel endothelial cells promotes pericyte coverage and decreases hypoxia in mouse tumour models, and correlative evidence suggests that these processes influence cancer prognosis in humans.
759 Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.
758 Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
757 Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
756 Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
755 Rabies Virus-Inspired Silica-Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors.
754 The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1.
753 Effective combinatorial immunotherapy for castration-resistant prostate cancer.
752 LACTB is a tumour suppressor that modulates lipid metabolism and cell state.
751 A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.
750 Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention.
749 Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
748 Integrated genomic and molecular characterization of cervical cancer.
747 Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia.
746 Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
745 Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
744 Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes.
743 High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
742 Profiling of melanoma patients treated with checkpoint blockade reveals TCR clonality and copy number loss as correlates of therapeutic response.